Sale!

CHRND Gene Myasthenic Syndrome Congenital Type 3B Fast-Channel Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CHRND Gene Myasthenic Syndrome Congenital Type 3B Fast-Channel NGS Genetic DNA Test is a sophisticated diagnostic tool that identifies mutations in the CHRND gene responsible for congenital myasthenic syndrome type 3B. This comprehensive genetic analysis utilizes next-generation sequencing technology to detect fast-channel mutations affecting acetylcholine receptor function. The test is crucial for individuals experiencing muscle weakness, fatigue, respiratory difficulties, or feeding problems from infancy. Results provide definitive diagnosis, guide treatment strategies, and enable genetic counseling for family planning. Available for only $500 USD, this test offers valuable insights into inherited neuromuscular conditions and helps optimize patient management approaches.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CHRND Gene Myasthenic Syndrome Congenital Type 3B Fast-Channel NGS Genetic DNA Test

Comprehensive Genetic Testing for Congenital Myasthenic Syndromes

The CHRND Gene Myasthenic Syndrome Congenital Type 3B Fast-Channel NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying specific genetic mutations associated with congenital myasthenic syndromes (CMS). This specialized test focuses on the CHRND gene, which encodes the delta subunit of the acetylcholine receptor – a critical component in neuromuscular transmission. When mutations occur in this gene, they can lead to fast-channel congenital myasthenic syndrome type 3B, characterized by impaired neuromuscular junction function and resulting in muscle weakness and fatigue.

What This Advanced Genetic Test Detects

Our comprehensive NGS-based analysis specifically targets:

  • Pathogenic variants in the CHRND gene associated with fast-channel congenital myasthenic syndrome
  • Mutations affecting acetylcholine receptor delta subunit function
  • Genetic alterations that disrupt normal neuromuscular transmission
  • Inherited patterns of congenital myasthenic syndromes
  • Specific fast-channel mutations that accelerate receptor channel closure

Who Should Consider This Genetic Test?

This specialized genetic testing is recommended for individuals presenting with:

  • Early-onset muscle weakness and fatigue
  • Respiratory difficulties in infancy or childhood
  • Feeding problems and poor weight gain in newborns
  • Ptosis (drooping eyelids) and ophthalmoplegia
  • Family history of congenital myasthenic syndromes
  • Unexplained neuromuscular symptoms with normal acetylcholine receptor antibody tests
  • Suspected inherited neuromuscular junction disorders

Significant Benefits of CHRND Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Definitive Diagnosis: Confirms or rules out CHRND-related congenital myasthenic syndrome
  • Personalized Treatment: Guides appropriate therapeutic interventions including cholinesterase inhibitors
  • Genetic Counseling: Enables informed family planning decisions
  • Prognostic Information: Helps predict disease progression and management needs
  • Early Intervention: Facilitates timely treatment to improve quality of life
  • Family Screening: Identifies at-risk relatives for preventive monitoring

Understanding Your Genetic Test Results

Our comprehensive genetic report provides clear interpretation of your results:

  • Positive Result: Indicates the presence of pathogenic CHRND mutations, confirming congenital myasthenic syndrome type 3B diagnosis
  • Negative Result: Suggests CHRND mutations are not the cause of symptoms, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation
  • Carrier Status: Determines inheritance patterns and recurrence risks

All results include detailed explanations and recommendations for next steps, with genetic counseling available to help you understand the implications for your health and family.

Test Pricing and Availability

Test Name Discount Price Regular Price
CHRND Gene Myasthenic Syndrome Congenital Type 3B Fast-Channel NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States, with convenient locations in:

  • New York City, NY
  • Los Angeles, CA
  • Chicago, IL
  • Houston, TX
  • Phoenix, AZ
  • Philadelphia, PA
  • San Antonio, TX
  • San Diego, CA
  • Dallas, TX
  • San Jose, CA

Our network of certified genetic counselors and neurologists ensures you receive expert guidance throughout the testing process.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neuromuscular symptoms affect your quality of life. Our CHRND genetic testing provides the answers you need for proper diagnosis and treatment planning. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spot cards, getting tested has never been more convenient.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your CHRND Gene Myasthenic Syndrome Congenital Type 3B Fast-Channel NGS Genetic DNA Test. Take control of your genetic health with confidence and clarity.